Bridging Gaps in Meningococcal Protection: Pharmacist-Led Approaches to Vaccination and Public Health Equity

Program Description

Invasive meningococcal disease (IMD) remains a critical public health challenge, as this devastating bacterial infection can lead to permanent complications including hearing loss, limb amputations, and organ failure within just 24 hours of onset. Despite these severe risks, vaccination coverage in the United States remains suboptimal and uneven across serotypes MenACWY and MenB, and this existing coverage gap is often made worse by public confusion regarding the various serogroups and the nuances in vaccine schedules. A key focus of this program will be utilizing updated guideline recommendations and evidence to support the pharmacist's role as a partner in individualized vaccination planning. As the meningococcal vaccine landscape shifts with the use of pentavalent (MenABCWY) vaccines, pharmacists require a thorough understanding of the appropriate role of the MenACWY, MenB, and MenABCWY vaccines, as well as the latest guideline recommendations to ensure appropriate and widespread vaccine uptake. By mastering these clinical updates and shared decision-making strategies, pharmacists can lead the charge in preventing the devastating personal and economic burdens associated with meningococcal disease. This activity will connect the latest vaccine guidance with the practical needs of the pharmacy team, featuring patient counseling video vignettes that demonstrate effective communication techniques to improve vaccine confidence.

Target audience: Community Pharmacist
Type of activity: Application
Release date: May 25, 2026
Expiration date: May 25, 2027
Learner level: Foundational
Time to complete activity: 1.5 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Evaluate recent trends in meningococcal disease incidence and serogroup distribution to identify populations at increased risk.
• Compare and apply current evidence on the immunogenicity, safety, and duration of protection of available meningococcal vaccines, including MenACWY and MenB formulations, to guide vaccine selection.
• Assess the impact of social determinants of health on meningococcal vaccination disparities across diverse populations.
• Implement pharmacist-driven strategies and community-based interventions to increase meningococcal vaccine awareness, accessibility, and uptake.